Low bone mineral density (BMD) is prevalent in human immunodeficiency virus (HIV)-
infected subjects. Initiation of antiretroviral therapy is associated with a 2%–6% decrease in …

The success of antiretroviral therapy in treating HIV infection has greatly prolonged life
expectancy in affected individuals, transforming the disease into a chronic condition. A …

Context: Reduced bone mineral density has been demonstrated among HIV-infected
patients, but fracture prevalence is unknown. Objective: The objective of the study was to …

Background HIV infection has been associated with an increased risk of fragility fracture. We
explored whether or not this increased risk persisted in HIV infected and uninfected men …

La actualización de estas recomendaciones de tratamiento antirretroviral del adulto se han
consensuado por un panel de expertos del Grupo de Estudio de Sida y del Plan Nacional …

Background: There is a high prevalence of bone demineralization among HIV-infected
patients but mechanisms of alteration of bone turnover are still unclear and it is thought to be …

Background: Low bone mineral density (BMD) is an emerging metabolic condition in HIV-
infected patients; however, data on progression of this disease are scarce. Methods: We …

A meta-analysis was conducted to evaluate the prevalence of osteopenia/osteoporosis in
human immunodeficiency virus (HIV)-infected individuals. The prevalence of osteopenia …

Several reports have suggested an increased prevalence of osteopenia and osteoporosis in
HIV-infected individuals. Vitamin D deficiency may be a risk factor for osteoporosis and bone …

Background: Disability and frailty are associated with osteoporosis, obesity, and sarcopenia.
HIV-infected persons have early functional impairment, but the association between body …